New analysis from Avalere finds that the proportion of Medicare Advantage beneficiaries enrolled in plans with 4 or more stars climbed from 38% in 2014 to 60% in 2015.
New analysis from Avalere finds that the proportion of Medicare Advantage (MA) beneficiaries enrolled in plans with 4 or more stars climbed from 38% in 2014 to 60% in 2015.
Meanwhile, MA plans with 3.5 stars or lower went from 60% enrollment in 2014 to only 39% in 2015. Plans receive star ratings in MA based on their performance on a series of quality measures. Star ratings are designed to help beneficiaries choose between plan options.
“The shift to higher star plans is a result of beneficiaries gravitating toward plans that have higher star ratings,” said Christine Harhaj, senior manager at Avalere.
Read more at Avalere: http://bit.ly/1DAA4kp
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More